IL145771A0 - Low-molecular inhibitors of complement proteases - Google Patents
Low-molecular inhibitors of complement proteasesInfo
- Publication number
- IL145771A0 IL145771A0 IL14577100A IL14577100A IL145771A0 IL 145771 A0 IL145771 A0 IL 145771A0 IL 14577100 A IL14577100 A IL 14577100A IL 14577100 A IL14577100 A IL 14577100A IL 145771 A0 IL145771 A0 IL 145771A0
- Authority
- IL
- Israel
- Prior art keywords
- low
- molecular inhibitors
- complement proteases
- complement
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B43/00—Formation or introduction of functional groups containing nitrogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19915930 | 1999-04-09 | ||
PCT/EP2000/002710 WO2000061608A2 (fr) | 1999-04-09 | 2000-03-28 | Inhibiteurs de faible poids moleculaire des proteases du complement |
Publications (1)
Publication Number | Publication Date |
---|---|
IL145771A0 true IL145771A0 (en) | 2002-07-25 |
Family
ID=7903946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14577100A IL145771A0 (en) | 1999-04-09 | 2000-03-28 | Low-molecular inhibitors of complement proteases |
Country Status (22)
Country | Link |
---|---|
US (1) | US6683055B1 (fr) |
EP (1) | EP1169338B1 (fr) |
JP (1) | JP4489976B2 (fr) |
KR (1) | KR20010108477A (fr) |
CN (1) | CN1351609A (fr) |
AT (1) | ATE281466T1 (fr) |
AU (1) | AU4111700A (fr) |
BG (1) | BG105978A (fr) |
BR (1) | BR0009678A (fr) |
CA (1) | CA2369378A1 (fr) |
CZ (1) | CZ20013577A3 (fr) |
DE (1) | DE50008510D1 (fr) |
HK (1) | HK1045846A1 (fr) |
HU (1) | HUP0203167A3 (fr) |
IL (1) | IL145771A0 (fr) |
MX (1) | MXPA01010114A (fr) |
NO (1) | NO20014876L (fr) |
PL (1) | PL351441A1 (fr) |
SK (1) | SK14232001A3 (fr) |
TR (1) | TR200102913T2 (fr) |
WO (1) | WO2000061608A2 (fr) |
ZA (2) | ZA200107890B (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1355810A (zh) * | 1999-04-09 | 2002-06-26 | 巴斯福股份公司 | 凝血酶抑制剂的前体药物 |
JP2004506648A (ja) * | 2000-08-11 | 2004-03-04 | コーバス インターナショナル, インコーポレイテッド | ウロキナーゼおよび血管形成の非共有結合性インヒビター |
ATE517910T1 (de) * | 2000-08-11 | 2011-08-15 | Wilex Ag | NICHT-KOVALENTE INHIBITOREN VON UROKINASE UND BLUTGEFÄßBILDUNG |
WO2003070229A2 (fr) * | 2002-02-22 | 2003-08-28 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Utilisation d'inhibiteurs de proteinases pour le traitement de maladies auto-immunes |
AU2003220222A1 (en) | 2002-03-13 | 2003-09-29 | Signum Biosciences, Inc. | Modulation of protein methylation and phosphoprotein phosphate |
EP1499306A4 (fr) | 2002-04-12 | 2007-03-28 | Merck & Co Inc | Amides bicycliques |
EP2266606B1 (fr) * | 2003-05-15 | 2014-09-10 | Genentech, Inc. | Méthodes et compositions pour la prévention et traitement du sepsis |
TW200519105A (en) * | 2003-10-20 | 2005-06-16 | Lg Life Science Ltd | Novel inhibitors of DPP-IV, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent |
CN1304568C (zh) * | 2004-07-05 | 2007-03-14 | 中国人民解放军第二军医大学 | 新型人补体C1r样丝氨酸蛋白酶类似物,其编码序列及用途 |
US7923041B2 (en) | 2005-02-03 | 2011-04-12 | Signum Biosciences, Inc. | Compositions and methods for enhancing cognitive function |
CA2601777A1 (fr) * | 2005-02-03 | 2006-08-10 | Signum Biosciences, Inc. | Compositions et procedes pour l'amelioration de la fonction cognitive |
US7385066B2 (en) * | 2005-03-16 | 2008-06-10 | Janssen Pharmaceutica N.V. | Thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
EP2282735B1 (fr) | 2008-04-21 | 2019-01-16 | Signum Biosciences, Inc. | Modulateurs du pp2a pour traiter alzheimer, parkinson, diabete |
CN102464701B (zh) * | 2010-11-08 | 2015-10-21 | 上海医药工业研究院 | 一类新型化合物、其制备方法及用途 |
US9079929B2 (en) | 2011-10-14 | 2015-07-14 | Bristol-Myers Squibb Company | Substituted tetrahydroisoquinoline compounds as factor XIa inhibitors |
EP2766345B1 (fr) | 2011-10-14 | 2016-03-16 | Bristol-Myers Squibb Company | Composés tétrahydroisoquinolines substitués en tant qu'inhibiteurs du facteur xia |
LT2766346T (lt) | 2011-10-14 | 2017-06-12 | Bristol-Myers Squibb Company | Pakeistieji tetrahidroizochinolino junginiai, kaip faktoriaus xia inhibitoriai |
EP2906541B1 (fr) | 2012-10-12 | 2017-11-22 | Bristol-Myers Squibb Company | Composés de tetrahydroisoquinoline substitués par guanidine et amine en tant qu'inhibiteurs de factor xia |
DK2906551T3 (en) | 2012-10-12 | 2018-05-22 | Bristol Myers Squibb Co | CRYSTALLIC FORMS OF A FACTOR XIA INHIBITOR |
WO2014059202A1 (fr) | 2012-10-12 | 2014-04-17 | Bristol-Myers Squibb Company | Composés de tétrahydroisoquinoléine substitués par guanidine comme inhibiteurs du facteur xia |
JP6479763B2 (ja) | 2013-03-25 | 2019-03-06 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 第xia因子阻害剤としての置換アゾール含有のテトラヒドロイソキノリン |
WO2015116886A1 (fr) | 2014-01-31 | 2015-08-06 | Bristol-Myers Squibb Company | Macrocycles à groupes hétérocycliques p2' servant d'inhibiteurs du facteur xia |
NO2760821T3 (fr) | 2014-01-31 | 2018-03-10 | ||
ES2714283T3 (es) | 2014-09-04 | 2019-05-28 | Bristol Myers Squibb Co | Macrociclos de diamida que son inhibidores de FXIa |
US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
AU2020245434A1 (en) * | 2019-03-22 | 2021-09-30 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement mediated disorders |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3738910A1 (de) | 1987-11-17 | 1989-05-24 | Basf Ag | Tributylammoniumsalz von 1,1-dicyano-2-hydroxy-3-chlorprop-1-en, ein verfahren zu seiner herstellung sowie ein verfahren zur herstellung von 2-amino-4-chlor-3-cyano-5-formylthiophen |
AU675981B2 (en) * | 1992-12-02 | 1997-02-27 | Bristol-Myers Squibb Company | Guanidinyl-substituted heterocyclic thrombin inhibitors |
SE9301916D0 (sv) * | 1993-06-03 | 1993-06-03 | Ab Astra | New peptides derivatives |
DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
DE4443390A1 (de) * | 1994-12-06 | 1996-06-13 | Basf Ag | Neue dipeptidische p-Amidinobenzylamide mit N-terminalen Sulfonyl- bzw. Aminosulfonylresten |
KR19980702112A (ko) | 1995-02-10 | 1998-07-15 | 페라 스타르크,요헨 카르크 | 트롬빈 억제제 |
MX9706069A (es) * | 1995-02-17 | 1997-10-31 | Basf Ag | Nuevos inhibidores de la trombina. |
AR005245A1 (es) * | 1995-12-21 | 1999-04-28 | Astrazeneca Ab | Prodrogas de inhibidores de trombina, una formulación farmaceutica que las comprende, el uso de dichas prodrogas para la manufactura de un medicamento y un procedimiento para su preparacion |
DE19632773A1 (de) | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Thrombininhibitoren |
DE19632772A1 (de) * | 1996-08-14 | 1998-02-19 | Basf Ag | Neue Benzamidine |
DE19635674A1 (de) | 1996-09-03 | 1998-03-05 | Basf Ag | Verfahren zur Herstellung von Amidinen |
US6653340B1 (en) * | 1997-06-03 | 2003-11-25 | Biocryst Pharmaceuticals, Inc. | Compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation |
JP2002501081A (ja) * | 1998-01-26 | 2002-01-15 | ビーエーエスエフ アクチェンゲゼルシャフト | トロンビンインヒビター |
EP1049673A1 (fr) * | 1998-01-26 | 2000-11-08 | Basf Aktiengesellschaft | Amidines heterocycliques utilisees comme inhibiteurs de la kallicreine |
-
2000
- 2000-03-28 SK SK1423-2001A patent/SK14232001A3/sk unknown
- 2000-03-28 IL IL14577100A patent/IL145771A0/xx unknown
- 2000-03-28 MX MXPA01010114A patent/MXPA01010114A/es unknown
- 2000-03-28 CN CN00807468A patent/CN1351609A/zh active Pending
- 2000-03-28 KR KR1020017012848A patent/KR20010108477A/ko not_active Application Discontinuation
- 2000-03-28 HU HU0203167A patent/HUP0203167A3/hu unknown
- 2000-03-28 CZ CZ20013577A patent/CZ20013577A3/cs unknown
- 2000-03-28 DE DE50008510T patent/DE50008510D1/de not_active Expired - Lifetime
- 2000-03-28 CA CA002369378A patent/CA2369378A1/fr not_active Abandoned
- 2000-03-28 JP JP2000611550A patent/JP4489976B2/ja not_active Expired - Fee Related
- 2000-03-28 AT AT00920597T patent/ATE281466T1/de not_active IP Right Cessation
- 2000-03-28 TR TR2001/02913T patent/TR200102913T2/xx unknown
- 2000-03-28 BR BR0009678-4A patent/BR0009678A/pt not_active IP Right Cessation
- 2000-03-28 WO PCT/EP2000/002710 patent/WO2000061608A2/fr active IP Right Grant
- 2000-03-28 EP EP00920597A patent/EP1169338B1/fr not_active Expired - Lifetime
- 2000-03-28 AU AU41117/00A patent/AU4111700A/en not_active Abandoned
- 2000-03-28 PL PL00351441A patent/PL351441A1/xx not_active Application Discontinuation
- 2000-03-30 US US09/539,811 patent/US6683055B1/en not_active Expired - Lifetime
-
2001
- 2001-09-26 ZA ZA200107890A patent/ZA200107890B/xx unknown
- 2001-09-28 ZA ZA200107978A patent/ZA200107978B/xx unknown
- 2001-10-04 BG BG105978A patent/BG105978A/bg unknown
- 2001-10-08 NO NO20014876A patent/NO20014876L/no unknown
-
2002
- 2002-09-26 HK HK02107037.8A patent/HK1045846A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
BG105978A (bg) | 2002-07-31 |
ATE281466T1 (de) | 2004-11-15 |
AU4111700A (en) | 2000-11-14 |
JP2002542164A (ja) | 2002-12-10 |
ZA200107978B (en) | 2003-03-26 |
PL351441A1 (en) | 2003-04-22 |
NO20014876L (no) | 2001-12-04 |
ZA200107890B (en) | 2003-11-26 |
HK1045846A1 (zh) | 2002-12-13 |
MXPA01010114A (es) | 2002-07-30 |
SK14232001A3 (sk) | 2002-06-04 |
CA2369378A1 (fr) | 2000-10-19 |
JP4489976B2 (ja) | 2010-06-23 |
EP1169338B1 (fr) | 2004-11-03 |
BR0009678A (pt) | 2002-01-22 |
CN1351609A (zh) | 2002-05-29 |
DE50008510D1 (de) | 2004-12-09 |
KR20010108477A (ko) | 2001-12-07 |
HUP0203167A3 (en) | 2003-09-29 |
HUP0203167A2 (hu) | 2003-02-28 |
EP1169338A2 (fr) | 2002-01-09 |
US6683055B1 (en) | 2004-01-27 |
WO2000061608A2 (fr) | 2000-10-19 |
TR200102913T2 (tr) | 2002-01-21 |
CZ20013577A3 (cs) | 2002-07-17 |
WO2000061608A3 (fr) | 2001-01-11 |
NO20014876D0 (no) | 2001-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL145771A0 (en) | Low-molecular inhibitors of complement proteases | |
WO2002051470A3 (fr) | Systemes d'injection | |
HK1029124A1 (en) | Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them. | |
HUP0200347A3 (en) | N-cyanomethylamides as protease inhibitors, pharmaceutical compositions containing them and their use | |
AU3710000A (en) | Initiator/amidine complexes, systems comprising the complexes, and polymerized compositions made therewith | |
MY112351A (en) | Polishing composition | |
IL134042A0 (en) | Modified dorsal tissue affecting factor and compositions | |
AU5751600A (en) | Eliminating gas blocking in electrokinetic pumping systems | |
ZA992549B (en) | Incorporation of active substances in carrier matrixes. | |
GB9717905D0 (en) | Lipid-containing compositions and uses thereof | |
HUP9900390A3 (en) | Serine protease inhibitors, and pharmaceutical compositions containing them | |
MXPA01010404A (es) | Peptidos moduladores de adhesion y metodos para utilizarlos. | |
WO2002043706A3 (fr) | Compositions a liberation prolongee et compositions a liberation retardee, a base de prolamines | |
CA95793S (en) | Paving stone | |
AU2001282857A1 (en) | Peptide and polypeptide inhibitors of complement c1s | |
AU2001244286A1 (en) | Peptide sequences comprising one or several protein binding units of the ena/vasp family, and uses thereof | |
NZ525774A (en) | Use of SARP-1 for the treatment and/or prevention of scleroderma | |
ZA946325B (en) | Retroviral protease inhibitors and combinations thereof. | |
ZA9710254B (en) | LH-RH peptide analogues, their uses and pharmaceutical composition containing them. | |
HK1041689A1 (en) | ((Aminoiminomethyl)amino) alkanecarboxamides and their applications in therapy. | |
IT1290910B1 (it) | 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive | |
ES2178911A1 (es) | Peptidos bioactivos derivados de las transferrinas. | |
ZA9810833B (en) | Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors. | |
MXPA03002923A (es) | Inhibidores de proteasas serina de peso molecular inferior que poseen radicales polihidroxialquilo y polihidroxicicloalquilo. | |
AU7361000A (en) | Epithelial protein lost in neoplasm (eplin) |